Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents

被引:43
作者
Wang, Xiaoli [1 ,2 ]
Wang, Linna [1 ,3 ]
Huang, Zhangjian [1 ,2 ]
Sheng, Xiao [1 ,2 ]
Li, Tingting [1 ,3 ]
Ji, Hui [1 ,3 ]
Xu, Jinyi [1 ,2 ]
Zhang, Yihua [1 ,2 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Ctr Drug Discovery, Nanjing 210009, Peoples R China
[3] China Pharmaceut Univ, Dept Pharmacol, Nanjing 210009, Peoples R China
关键词
3-n-Butylphthalide (NBP); 6-Amino-3-n-butylphthalide; NO-releasing derivatives; Antiplatelet agents; Ischemic stroke; STROKE; DRUGS;
D O I
10.1016/j.bmcl.2013.02.035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide were designed, synthesized and evaluated as potential antiplatelet agents. Compound 10b significantly inhibited the adenosine diphosphate (ADP)-induced platelet aggregation in vitro, superior to 6-amino-3-n-butylphthalide, 3-n-butylphthalide (NBP) and ticlopidine. Meanwhile 10b released moderate levels of NO, which could be beneficial for improving cardiovascular and cerebral circulation. Furthermore, 10b had an enhanced aqueous solubility relative to NBP. These findings may provide new insights into the development of novel antiplatelet agents for the treatment of thrombosis-related ischemic stroke. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1985 / 1988
页数:4
相关论文
共 17 条
[1]   Carbonic anhydrase inhibitors: Water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects [J].
Casini, A ;
Scozzafava, A ;
Mincione, F ;
Menabuoni, L ;
Ilies, MA ;
Supuran, CT .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4884-4892
[2]   THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE [J].
FURCHGOTT, RF ;
ZAWADZKI, JV .
NATURE, 1980, 288 (5789) :373-376
[3]  
Guo ZR., 2002, Patent No. [CN/1330069, 1330069]
[4]   Preventable stroke and stroke prevention [J].
Hankey, GJ .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (08) :1638-1645
[5]   Ethanesulfohydroxamic Acid Ester Prodrugs of Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Synthesis, Nitric oxide and Nitroxyl Release, Cyclooxygenase Inhibition, Anti-inflammatory, and Ulcerogenicity Index Studies [J].
Huang, Zhangjian ;
Velazquez, Carlos A. ;
Abdellatif, Khaled R. A. ;
Chowdhury, Morshed A. ;
Reisz, Julie A. ;
DuMond, Jenna F. ;
King, S. Bruce ;
Knaus, Edward E. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (05) :1356-1364
[6]   Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups [J].
Jones, Michael ;
Inkielewicz, Iwona ;
Medina, Carlos ;
Santos-Martinez, Maria Jose ;
Radomski, Anna ;
Radomski, Marek W. ;
Lally, Maeve N. ;
Moriarty, Louise M. ;
Gaynor, Joanne ;
Carolan, Ciaran G. ;
Khan, Denise ;
O'Byrne, Paul ;
Harmon, Shona ;
Holland, Valerie ;
Clancy, John M. ;
Gilmer, John F. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) :6588-6598
[7]   dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP [J].
Liu, Chun-Ling ;
Liao, Song-Jie ;
Zeng, Jin-Sheng ;
Lin, Jian-Wen ;
Li, Chang-Xin ;
Xie, Long-Chang ;
Shi, Xiao-Geng ;
Huang, Ru-Xun .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 260 (1-2) :106-113
[8]   Triggers, targets and treatments for thrombosis [J].
Mackman, Nigel .
NATURE, 2008, 451 (7181) :914-918
[9]   NO-releasing hybrids of cardiovascular drugs [J].
Martelli, A ;
Rapposelli, S ;
Calderone, V .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (06) :609-625
[10]  
Megson IL, 2002, EXPERT OPIN INV DRUG, V11, P587